Codexis (CDXS) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazilās Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiativeĀ
- CAE agrees to sell Flightscape unit to SITA for $500 million
- Stocks, bonds edge up ahead of 'formidable' week for risk
Stifel on Codexis, Inc. (CDXS): 'Key Milestones On the Horizon in 2H25'
August 14, 2025 10:35 AM EDTStifel analyst Daniel Arias reiterated a Buy rating and $5.00 price target on Codexis, Inc. (NASDAQ: CDXS).
The analyst comments "CDXS beat consensus on revs and provided a briefing on the encouraging status of the Pharma Biocatalysis business and the ECO Synthesis... More



